Back to current studies

Quit Battling the Sleepiness of Narcolepsy!

NeuroTrials Research is conducting a new research study evaluating the safety and efficacy of an investigational drug in treating adults with narcolepsy type 1.

All study-related care and study drug will be provided at no cost, and participants may be compensated for time and travel.

You may qualify if you:

• are 18 –64 years old
• have a primary diagnosis of narcolepsy Type 1
• experience excessive daytime sleepiness
• are otherwise in general good health​ with no other sleep disorders